Supriya Lifescience Limited (BOM:543434)

Market Cap	54.80B +2.7%
Revenue (ttm)	7.35B +9.7%
Net Income	1.85B +6.2%
EPS	23.04 +6.4%
Shares Out	n/a
PE Ratio	29.58
Forward PE	23.34
Dividend	1.00 (0.15%)
Ex-Dividend Date	Sep 4, 2025

Volume	5,519
Average Volume	6,944
Open	677.00
Previous Close	684.90
Day's Range	677.00 - 701.95
52-Week Range	556.85 - 841.70
Beta	n/a
RSI	43.92
Earnings Date	Feb 9, 2026

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, ...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 515
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543434

Financial Performance

In fiscal year 2025, Supriya Lifescience's revenue was 6.96 billion, an increase of 22.12% compared to the previous year's 5.70 billion. Earnings were 1.88 billion, an increase of 57.80%.